CRISPR and CAS Gene Market to Reach US$ 2.9 Billion by 2027, Exhibiting a CAGR of 22.8%, Finds Coherent Market Insights
![]() |
CRISPR and CAS Gene Market |
The global CRISPR and CAS Gene Market is estimated to
be valued at US$ 830.7 Mn in 2020
and is expected to exhibit a CAGR of
22.8% over the forecast period 2020-2027, as highlighted in a new report
published by Coherent Market Insights.
Market Overview:
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and CAS
(CRISPR-associated) genes are a revolutionary gene-editing technique that
allows scientists to edit specific genes within an organism. This technology
has gained significant attention in recent years due to its potential
applications in various fields such as agriculture, healthcare, and biomedical
research. CRISPR and CAS genes offer several advantages, including high
efficiency, accuracy, and cost-effectiveness compared to traditional
gene-editing techniques. The need for precise and effective gene-editing tools
to address various genetic disorders and develop genetically modified crops is
driving the demand for CRISPR and CAS gene technology.
Market Key Trends:
One key trend in the CRISPR and CAS gene market is the increasing adoption of
CRISPR technology in therapeutic applications. CRISPR gene editing holds great
promise for treating genetic disorders by correcting or modifying
disease-causing genes. The ability to edit genes with precision opens up new
avenues for developing targeted therapies for diseases such as cancer, cystic
fibrosis, and sickle cell anemia. Additionally, CRISPR technology is being
explored for developing personalized cancer treatments and immunotherapies. The
growing number of clinical trials using CRISPR-based therapies and the
increasing investment from pharmaceutical companies in this field are driving
the market growth.
The market is witnessing a surge in strategic collaborations and partnerships
among key players to expand their product portfolios and strengthen their
market presence. For instance, Thermo Fisher Scientific Inc., Merck KGaA
(Sigma-Aldrich
PEST Analysis:
Political: The political landscape can influence the Crispr
and Cas Gene Market. Governments across the globe have different
regulations and policies regarding genetic engineering, which can impact the
market. For example, some countries may have stricter regulations, making it
more challenging for companies to conduct research and development in this
field.
Economic: The economic factors play a crucial role in the growth of the CRISPR
and CAS gene market. The market is expected to witness high growth with a CAGR of 22.8% over the forecast period.
This growth can be attributed to increasing investments in research and
development activities in the field of genetic engineering. Additionally, the
market is driven by the rising demand for advanced gene editing technologies in
various industries, such as healthcare and agriculture.
Social: The social factors influencing the market include the increasing
awareness and acceptance of genetic engineering among the general population.
The potential benefits of CRISPR and CAS gene technologies, such as treating
genetic diseases and increasing crop yields, are driving the social acceptance.
However, there may still be ethical concerns and debates regarding the use of
these technologies, which can impact market growth.
Technological: Technological advancements in CRISPR and CAS gene editing
technologies are a significant driver for the market. The development of more
efficient and precise gene editing tools and techniques has expanded the scope
of applications for these technologies. Additionally, the increasing
availability and affordability of gene editing kits and services have also
contributed to the market growth.
Key Takeaways:
The global CRISPR and CAS gene market is expected to witness high growth,
exhibiting a CAGR of 22.8% over the
forecast period. This growth is driven by increasing investments in research
and development activities and the rising demand for advanced gene editing
technologies in various industries.
Regionally, North America is anticipated to be the fastest-growing and
dominating region in the CRISPR and CAS gene market. The region has a strong
presence of key market players and favorable government initiatives and
policies. Additionally, the region's well-established healthcare infrastructure
and high adoption of advanced technologies contribute to its dominance in the
market.
Key players operating in the CRISPR and CAS gene market include Thermo Fisher
Scientific Inc., Merck KGaA (Sigma-Aldrich), OriGene Technologies, Inc., New
England Biolabs, Cellecta, Inc., Agilent Technologies, Inc., Applied StemCell,
Inc., Synthego, Genscript, Mirus Bio LLC, Integrated DNA Technologies, Inc.,
and Mammoth Biosciences, Inc. These key players are actively involved in
research and development activities and have a strong market presence,
contributing to the overall growth of the market.
Comments
Post a Comment